AbbVie Inc (ABBV)
178.01
-1.19
(-0.66%)
USD |
NYSE |
Dec 27, 16:00
178.00
-0.01
(-0.01%)
After-Hours: 20:00
AbbVie SG&A Expense (Quarterly): 4.205B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen Inc | 1.625B |
| Gilead Sciences Inc | 1.433B |
| Johnson & Johnson | 5.278B |
| Eli Lilly and Co | 2.100B |
| Merck & Co Inc | 2.731B |